| Year |
Citation |
Score |
| 2019 |
Yu H, Janssen JM, Sawicki E, van Hasselt JGC, de Weger VA, Nuijen B, Schellens JHM, Beijnen JH, Huitema ADR. A Population Pharmacokinetic Model of Oral Docetaxel Coadministered With Ritonavir to Support Early Clinical Development. Journal of Clinical Pharmacology. PMID 31595980 DOI: 10.1002/Jcph.1532 |
0.503 |
|
| 2017 |
Krekels EHJ, van Hasselt JGC, van den Anker JN, Allegaert K, Tibboel D, Knibbe CAJ. Evidence-based drug treatment for special patient populations through model-based approaches. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. S22-S26. PMID 28502674 DOI: 10.1016/j.ejps.2017.05.022 |
0.318 |
|
| 2016 |
Jacobs BA, Deenen MJ, Pluim D, van Hasselt JG, Krähenbühl MD, van Geel RM, de Vries N, Rosing H, Meulendijks D, Burylo AM, Cats A, Beijnen JH, Huitema AD, Schellens JH. Pronounced between-subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers. British Journal of Clinical Pharmacology. PMID 27161955 DOI: 10.1111/Bcp.13007 |
0.684 |
|
| 2016 |
Meulendijks D, van Hasselt JG, Huitema AD, van Tinteren H, Deenen MJ, Beijnen JH, Cats A, Schellens JH. Renal function, body surface area, and age are associated with risk of early-onset fluoropyrimidine-associated toxicity in patients treated with capecitabine-based anticancer regimens in daily clinical care. European Journal of Cancer (Oxford, England : 1990). 54: 120-130. PMID 26761784 DOI: 10.1016/J.Ejca.2015.10.013 |
0.707 |
|
| 2015 |
van Hasselt J, Gupta A, Hussein Z, Beijnen JH, Schellens J, Huitema A. Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin. Cpt: Pharmacometrics & Systems Pharmacology. 4: 386-95. PMID 26312162 DOI: 10.1002/psp4.49 |
0.577 |
|
| 2015 |
van Hasselt J, Gupta A, Hussein Z, Beijnen JH, Schellens J, Huitema A. Integrated Simulation Framework for Toxicity, Dose Intensity, Disease Progression, and Cost Effectiveness for Castration-Resistant Prostate Cancer Treatment With Eribulin. Cpt: Pharmacometrics & Systems Pharmacology. 4: 374-85. PMID 26312161 DOI: 10.1002/psp4.48 |
0.607 |
|
| 2015 |
van Hasselt JG, Allegaert K, van Calsteren K, Beijnen JH, Schellens JH, Huitema AD. Corrigendum to "Semiphysiological versus Empirical Modelling of the Population Pharmacokinetics of Free and Total Cefazolin during Pregnancy". Biomed Research International. 2015: 124035. PMID 25922829 DOI: 10.1155/2015/124035 |
0.705 |
|
| 2015 |
Frederix GW, Severens JL, Hövels AM, van Hasselt JG, Hooiveld MJ, Neven P, Raaijmakers JA, Schellens JH. Real world cost of human epidermal receptor 2-positive metastatic breast cancer patients: a longitudinal incidence-based observational costing study in the Netherlands and Belgium. European Journal of Cancer Care. 24: 340-54. PMID 25413216 DOI: 10.1111/Ecc.12266 |
0.391 |
|
| 2015 |
Yu H, Steeghs N, Kloth JS, de Wit D, van Hasselt JG, van Erp NP, Beijnen JH, Schellens JH, Mathijssen RH, Huitema AD. Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662. British Journal of Clinical Pharmacology. 79: 809-19. PMID 25393890 DOI: 10.1111/Bcp.12550 |
0.724 |
|
| 2015 |
Van Hasselt JGC, Gupta A, Hussein Z, Beijnen JH, Schellens JHM, Huitema ADR. Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated with Eribulin Cpt: Pharmacometrics and Systems Pharmacology. 4: 386-395. DOI: 10.1002/psp4.49 |
0.448 |
|
| 2015 |
Van Hasselt JGC, Gupta A, Hussein Z, Beijnen JH, Schellens JHM, Huitema ADR. Integrated Simulation Framework for Toxicity, Dose Intensity, Disease Progression, and Cost Effectiveness for Castration-Resistant Prostate Cancer Treatment with Eribulin Cpt: Pharmacometrics and Systems Pharmacology. 4: 374-385. DOI: 10.1002/psp4.48 |
0.434 |
|
| 2014 |
van Hasselt JG, van Eijkelenburg NK, Beijnen JH, Schellens JH, Huitema AD. Design of a drug-drug interaction study of vincristine with azole antifungals in pediatric cancer patients using clinical trial simulation. Pediatric Blood & Cancer. 61: 2223-9. PMID 25175364 DOI: 10.1002/Pbc.25198 |
0.705 |
|
| 2014 |
van Hasselt JG, Schellens JH, Beijnen JH, Huitema AD. Design of informative renal impairment studies: evaluation of the impact of design stratification on bias, precision and dose adjustment error. Investigational New Drugs. 32: 913-27. PMID 24788562 DOI: 10.1007/S10637-014-0103-8 |
0.71 |
|
| 2014 |
van Hasselt JG, van Calsteren K, Heyns L, Han S, Mhallem Gziri M, Schellens JH, Beijnen JH, Huitema AD, Amant F. Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 2059-65. PMID 24713311 DOI: 10.1093/Annonc/Mdu140 |
0.58 |
|
| 2014 |
van Hasselt JG, Allegaert K, van Calsteren K, Beijnen JH, Schellens JH, Huitema AD. Semiphysiological versus empirical modelling of the population pharmacokinetics of free and total cefazolin during pregnancy. Biomed Research International. 2014: 897216. PMID 24672799 DOI: 10.1155/2014/897216 |
0.73 |
|
| 2014 |
Frederix GW, van Hasselt JG, Schellens JH, Hövels AM, Raaijmakers JA, Huitema AD, Severens JL. The impact of structural uncertainty on cost-effectiveness models for adjuvant endocrine breast cancer treatments: the need for disease-specific model standardization and improved guidance. Pharmacoeconomics. 32: 47-61. PMID 24263964 DOI: 10.1007/S40273-013-0106-X |
0.692 |
|
| 2013 |
Frederix GW, Severens JL, Hövels AM, van Hasselt JG, Raaijmakers JA, Schellens JH. Time-dependent resource use and costs associated with different states of disease in patients diagnosed with HER-2-positive metastatic breast cancer. Breast Cancer Research and Treatment. 139: 489-95. PMID 23645005 DOI: 10.1007/S10549-013-2532-Z |
0.384 |
|
| 2013 |
van Hasselt JG, Gupta A, Hussein Z, Beijnen JH, Schellens JH, Huitema AD. Population pharmacokinetic-pharmacodynamic analysis for eribulin mesilate-associated neutropenia. British Journal of Clinical Pharmacology. 76: 412-24. PMID 23601153 DOI: 10.1111/Bcp.12143 |
0.744 |
|
| 2013 |
van Hasselt JG, van Eijkelenburg NK, Huitema AD, Schellens JH, Schouten-van Meeteren AY. Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate. Antimicrobial Agents and Chemotherapy. 57: 2878-81. PMID 23571545 DOI: 10.1128/Aac.00068-13 |
0.671 |
|
| 2013 |
Frederix GW, van Hasselt JG, Severens JL, Hövels AM, Huitema AD, Raaijmakers JA, Schellens JH. Development of a framework for cohort simulation in cost-effectiveness analyses using a multistep ordinary differential equation solver algorithm in R. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 33: 780-92. PMID 23515213 DOI: 10.1177/0272989X13476763 |
0.657 |
|
| 2013 |
Van Hasselt JGC, van Eijkelenburg NKA, Beijnen JH, Schellens JHM, Huitema ADR. Optimizing drug development of anti-cancer drugs in children using modelling and simulation British Journal of Clinical Pharmacology. 76: 30-47. PMID 23216601 DOI: 10.1111/Bcp.12062 |
0.476 |
|
| 2013 |
Mallaysamy S, Johnson MG, Rao PGM, Rajakannan T, Bathala L, Arumugam K, Van Hasselt JGC, Ramakrishna D. Population pharmacokinetics of lamotrigine in Indian epileptic patients European Journal of Clinical Pharmacology. 69: 43-52. PMID 22660444 DOI: 10.1007/s00228-012-1311-9 |
0.315 |
|
| 2012 |
Van Hasselt JGC, Schellens JHM, Mac Gillavry MR, Beijnen JH, Huitema ADR. Model-based evaluation and optimization of cardiac monitoring protocols for adjuvant treatment of breast cancer with trastuzumab Pharmaceutical Research. 29: 3499-3511. PMID 22907417 DOI: 10.1007/S11095-012-0845-Y |
0.473 |
|
| 2012 |
van Hasselt JG, van den Heuvel MM, Schellens JH, Beijnen JH, Brandsma D, Huitema AD. Severe cannabinoid intoxication in a patient with non-small-cell lung cancer. Journal of Palliative Care. 28: 60-1. PMID 22582474 |
0.689 |
|
| 2012 |
van Hasselt JC, van den Heuvel MM, Schellens JH, Beijnen JH, Brandsma D, Huitema A. Severe Cannabinoid Intoxication in A Patient with Non-Small-Cell Lung Cancer Journal of Palliative Care. 28: 60-61. DOI: 10.1177/082585971202800110 |
0.53 |
|
| 2011 |
van den Broek MP, Huitema AD, van Hasselt JG, Groenendaal F, Toet MC, Egberts TC, de Vries LS, Rademaker CM. Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures. Clinical Pharmacokinetics. 50: 461-9. PMID 21651313 DOI: 10.2165/11589160-000000000-00000 |
0.669 |
|
| 2011 |
Van Hasselt JGC, Boekhout AH, Beijnen JH, Schellens JHM, Huitema ADR. Population pharmacokinetic-pharmacodynamic analysis of trastuzumab- associated cardiotoxicity Clinical Pharmacology and Therapeutics. 90: 126-132. PMID 21633346 DOI: 10.1038/Clpt.2011.74 |
0.511 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2023 |
Janssen JM, Damoiseaux D, van Hasselt JGC, Amant FCH, van Calsteren K, Beijnen JH, Huitema ADR, Dorlo TPC. Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs. Clinical Pharmacokinetics. PMID 37351792 DOI: 10.1007/s40262-023-01263-1 |
0.292 |
|
| 2019 |
Illamola SM, Sherwin CM, van Hasselt JGC. Clinical Pharmacokinetics of Amikacin in Pediatric Patients: A Comprehensive Review of Population Pharmacokinetic Analyses. Clinical Pharmacokinetics. 57: 1217-1228. PMID 29572662 DOI: 10.1007/s40262-018-0641-x |
0.284 |
|
| 2018 |
de Vries Schultink AHM, Boekhout AH, Gietema JA, Burylo AM, Dorlo TPC, van Hasselt JGC, Schellens JHM, Huitema ADR. Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens. Journal of Pharmacokinetics and Pharmacodynamics. PMID 29429038 DOI: 10.1007/S10928-018-9579-8 |
0.272 |
|
| 2012 |
van den Broek MP, Groenendaal F, Toet MC, van Straaten HL, van Hasselt JG, Huitema AD, de Vries LS, Egberts AC, Rademaker CM. Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: a thermopharmacological approach. Clinical Pharmacokinetics. 51: 671-9. PMID 23018530 DOI: 10.1007/S40262-012-0004-Y |
0.262 |
|
| 2023 |
Zwep LB, Guo T, Nagler T, Knibbe CAJ, Meulman JJ, van Hasselt JGC. Virtual Patient Simulation Using Copula Modeling. Clinical Pharmacology and Therapeutics. PMID 37946529 DOI: 10.1002/cpt.3099 |
0.258 |
|
| 2020 |
Guo T, van Hest RM, Zwep LB, Roggeveen LF, Fleuren LM, Bosman RJ, van der Voort PHJ, Girbes ARJ, Mathot RAA, Elbers PWG, van Hasselt JGC. Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients. Pharmaceutical Research. 37: 171. PMID 32830297 DOI: 10.1007/S11095-020-02908-7 |
0.257 |
|
| 2023 |
Fu Y, Snelder N, Guo T, van der Graaf PH, van Hasselt JGC. Evaluation of a Cardiovascular Systems Model for Design and Analysis of Hemodynamic Safety Studies. Pharmaceutics. 15. PMID 37111660 DOI: 10.3390/pharmaceutics15041175 |
0.249 |
|
| 2020 |
Aulin LBS, De Paepe P, Dhont E, de Jaeger A, Vande Walle J, Vandenberghe W, McWhinney BC, Ungerer JPJ, van Hasselt JGC, De Cock PAJG. Population Pharmacokinetics of Unbound and Total Teicoplanin in Critically Ill Pediatric Patients. Clinical Pharmacokinetics. 60: 353-363. PMID 33030704 DOI: 10.1007/s40262-020-00945-4 |
0.24 |
|
| 2016 |
Illamola SM, Colom H, van Hasselt JG. Evaluating renal function and age as predictors of amikacin clearance in neonates: model-based analysis and optimal dosing strategies. British Journal of Clinical Pharmacology. 82: 793-805. PMID 27198625 DOI: 10.1111/bcp.13016 |
0.234 |
|
| 2022 |
Fu Y, Taghvafard H, Said MM, Rossman EI, Collins TA, Billiald-Desquand S, Leishman D, van der Graaf PH, van Hasselt JGC, Snelder N. A novel cardiovascular systems model to quantify drugs effects on the inter-relationship between contractility and other hemodynamic variables. Cpt: Pharmacometrics & Systems Pharmacology. PMID 35213797 DOI: 10.1002/psp4.12774 |
0.233 |
|
| 2022 |
Guo T, Abdulla A, Koch BCP, van Hasselt JGC, Endeman H, Schouten JA, Elbers PWG, Brüggemann RJM, van Hest RM. Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients. Clinical Pharmacokinetics. 61: 869-879. PMID 35262847 DOI: 10.1007/s40262-022-01114-5 |
0.231 |
|
| 2017 |
Ramamoorthy A, Sadler BM, van Hasselt JGC, Elassaiss-Schaap J, Kasichayanula S, Edwards AY, van der Graaf PH, Zhang L, Wagner JA. Crowdsourced Asparagus Urinary Odor Population Kinetics. Cpt: Pharmacometrics & Systems Pharmacology. PMID 29239147 DOI: 10.1002/psp4.12264 |
0.23 |
|
| 2023 |
Mehta K, Guo T, van der Graaf PH, van Hasselt JGC. Model-based dose optimization framework for bedaquiline, pretomanid and linezolid for the treatment of drug-resistant tuberculosis. British Journal of Clinical Pharmacology. 90: 463-474. PMID 37817504 DOI: 10.1111/bcp.15925 |
0.228 |
|
| 2020 |
Guo T, van Hest RM, Fleuren LM, Roggeveen LF, Bosman RJ, van der Voort PHJ, Girbes ARJ, Mathot RAA, van Hasselt JGC, Elbers PWG. Why we should sample sparsely and aim for a higher target: lessons from model-based therapeutic drug monitoring (TDM) of vancomycin in intensive care patients. British Journal of Clinical Pharmacology. PMID 32715505 DOI: 10.1111/Bcp.14498 |
0.224 |
|
| 2021 |
Zwep LB, Duisters KLW, Jansen M, Guo T, Meulman JJ, Upadhyay PJ, van Hasselt JGC. Identification of high-dimensional omics-derived predictors for tumor growth dynamics using machine learning and pharmacometric modeling. Cpt: Pharmacometrics & Systems Pharmacology. PMID 33792207 DOI: 10.1002/psp4.12603 |
0.222 |
|
| 2017 |
Yamamoto Y, Välitalo PA, Wong YC, Huntjens DR, Proost JH, Vermeulen A, Krauwinkel W, Beukers MW, Kokki H, Kokki M, Danhof M, van Hasselt JGC, de Lange ECM. Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approach. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 29133240 DOI: 10.1016/j.ejps.2017.11.011 |
0.221 |
|
| 2021 |
Aulin LBS, de Lange DW, Saleh MAA, van der Graaf PH, Völler S, van Hasselt JGC. Biomarker-Guided Individualization of Antibiotic Therapy. Clinical Pharmacology and Therapeutics. PMID 33559152 DOI: 10.1002/cpt.2194 |
0.221 |
|
| 2022 |
Yin A, van Hasselt JGC, Guchelaar HJ, Friberg LE, Moes DJAR. Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance. Scientific Reports. 12: 4206. PMID 35273301 DOI: 10.1038/s41598-022-08012-7 |
0.218 |
|
| 2011 |
Krekels EHJ, Van Hasselt JGC, Tibboel D, Danhof M, Knibbe CAJ. Systematic evaluation of the descriptive and predictive performance of Paediatric morphine population models Pharmaceutical Research. 28: 797-811. PMID 21153913 DOI: 10.1007/s11095-010-0333-1 |
0.218 |
|
| 2024 |
Yin A, Veerman GDM, van Hasselt JGC, Steendam CMJ, Dubbink HJ, Guchelaar HJ, Friberg LE, Dingemans AC, Mathijssen RHJ, Moes DJAR. Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib. Cpt: Pharmacometrics & Systems Pharmacology. PMID 38375997 DOI: 10.1002/psp4.13105 |
0.217 |
|
| 2010 |
Lo YL, Van Hasselt JGC, Heng SC, Lim CT, Lee TC, Charles BG. Population pharmacokinetics of vancomycin in premature malaysian neonates: Identification of predictors for dosing determination Antimicrobial Agents and Chemotherapy. 54: 2626-2632. PMID 20385872 DOI: 10.1128/AAC.01370-09 |
0.213 |
|
| 2020 |
Centanni M, Moes DJAR, Trocóniz IF, Ciccolini J, van Hasselt JGC. Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors. Clinical Pharmacokinetics. 58: 835-857. PMID 30815848 DOI: 10.1007/s40262-019-00748-2 |
0.211 |
|
| 2017 |
Kohler I, Hankemeier T, van der Graaf PH, Knibbe CAJ, van Hasselt JGC. Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 28502671 DOI: 10.1016/j.ejps.2017.05.018 |
0.207 |
|
| 2017 |
Yamamoto Y, Välitalo PA, Huntjens DR, Proost JH, Vermeulen A, Krauwinkel W, Beukers MW, van den Berg DJ, Hartman R, Cheong Wong Y, Danhof M, van Hasselt JGC, de Lange ECM. Predicting drug concentration-time profiles in multiple CNS compartments using a comprehensive physiologically-based pharmacokinetic model. Cpt: Pharmacometrics & Systems Pharmacology. PMID 28891201 DOI: 10.1002/psp4.12250 |
0.207 |
|
| 2012 |
Klumpers LE, Beumer TL, van Hasselt JGC, Lipplaa A, Karger LB, Kleinloog HD, Freijer JI, de Kam ML, van Gerven JMA. Novel Δ9-tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects British Journal of Clinical Pharmacology. 74: 42-53. PMID 22680341 DOI: 10.1111/j.1365-2125.2012.04164.x |
0.201 |
|
| 2012 |
Van Hasselt JGC, Green B, Morrish GA. Leveraging physiological data from literature into a pharmacokinetic model to support informative clinical study design in pregnant women Pharmaceutical Research. 29: 1609-1617. PMID 22246291 DOI: 10.1007/s11095-012-0671-2 |
0.199 |
|
| 2017 |
de Jesus Antunes N, van Dijkman SC, Lanchote VL, Wichert-Ana L, Coelho EB, Junior VA, Takayanagui OM, Tozatto E, van Hasselt JGC, Pasqua OD. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 28528287 DOI: 10.1016/j.ejps.2017.05.034 |
0.196 |
|
| 2017 |
Shim JV, Chun B, van Hasselt JGC, Birtwistle MR, Saucerman JJ, Sobie EA. Mechanistic Systems Modeling to Improve Understanding and Prediction of Cardiotoxicity Caused by Targeted Cancer Therapeutics. Frontiers in Physiology. 8: 651. PMID 28951721 DOI: 10.3389/Fphys.2017.00651 |
0.192 |
|
| 2012 |
van Hasselt JGC, Andrew MA, Hebert MF, Tarning J, Vicini P, Mattison DR. The status of pharmacometrics in pregnancy: Highlights from the 3rd American conference on pharmacometrics British Journal of Clinical Pharmacology. 74: 932-939. PMID 22452385 DOI: 10.1111/J.1365-2125.2012.04280.X |
0.191 |
|
| 2018 |
van Hasselt JGC, Iyengar R. Systems Pharmacology: Defining the Interactions of Drug Combinations. Annual Review of Pharmacology and Toxicology. PMID 30260737 DOI: 10.1146/annurev-pharmtox-010818-021511 |
0.187 |
|
| 2016 |
Nguyen TH, Mouksassi MS, Holford N, Al-Huniti N, Freedman I, Hooker AC, John J, Karlsson MO, Mould DR, Pérez Ruixo JJ, Plan EL, Savic R, van Hasselt JG, Weber B, Zhou C, et al. Model evaluation of continuous data pharmacometric models: Metrics and graphics. Cpt: Pharmacometrics & Systems Pharmacology. PMID 27884052 DOI: 10.1002/psp4.12161 |
0.179 |
|
| 2022 |
Mehta K, Guo T, Wallis RS, van der Graaf PH, van Hasselt JGC. Quantitative Systems Pharmacology Modeling Framework of Autophagy in Tuberculosis: Application to Adjunctive Metformin Host-Directed Therapy. Antimicrobial Agents and Chemotherapy. 66: e0036622. PMID 35862740 DOI: 10.1128/aac.00366-22 |
0.177 |
|
| 2015 |
van Hasselt JG, van der Graaf PH. Towards integrative systems pharmacology models in oncology drug development. Drug Discovery Today. Technologies. 15: 1-8. PMID 26464083 DOI: 10.1016/j.ddtec.2015.06.004 |
0.174 |
|
| 2015 |
van Hasselt JG, van der Graaf PH. Towards integrative systems pharmacology models in oncology drug development. Drug Discovery Today. Technologies. 15: 1-8. PMID 26464083 DOI: 10.1016/j.ddtec.2015.06.004 |
0.174 |
|
| 2022 |
Yin A, van Hasselt JGC, Guchelaar HJ, Friberg LE, Moes DJAR. Publisher Correction: Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance. Scientific Reports. 12: 4879. PMID 35318415 DOI: 10.1038/s41598-022-09014-1 |
0.173 |
|
| 2020 |
van Hasselt JGC, Rahman R, Hansen J, Stern A, Shim JV, Xiong Y, Pickard A, Jayaraman G, Hu B, Mahajan M, Gallo JM, Goldfarb J, Sobie EA, Birtwistle MR, Schlessinger A, et al. Transcriptomic profiling of human cardiac cells predicts protein kinase inhibitor-associated cardiotoxicity. Nature Communications. 11: 4809. PMID 32968055 DOI: 10.1038/s41467-020-18396-7 |
0.172 |
|
| 2016 |
van Hasselt JG, Rizk ML, Lala M, Chavez-Eng C, Visser SA, Kerbusch T, Danhof M, Rao G, van der Graaf PH. Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid. British Journal of Clinical Pharmacology. PMID 26852277 DOI: 10.1111/bcp.12901 |
0.171 |
|
| 2019 |
Yin A, Moes DJAR, van Hasselt JGC, Swen JJ, Guchelaar HJ. A review of mathematical models for tumor dynamics and treatment resistance evolution of solid tumors. Cpt: Pharmacometrics & Systems Pharmacology. PMID 31250989 DOI: 10.1002/psp4.12450 |
0.17 |
|
| 2023 |
Mehta K, Guo T, van der Graaf PH, van Hasselt JGC. Predictions of Bedaquiline and Pretomanid Target Attainment in Lung Lesions of Tuberculosis Patients using Translational Minimal Physiologically Based Pharmacokinetic Modeling. Clinical Pharmacokinetics. 62: 519-532. PMID 36802057 DOI: 10.1007/s40262-023-01217-7 |
0.17 |
|
| 2021 |
Aulin LBS, Liakopoulos A, van der Graaf PH, Rozen DE, van Hasselt JGC. Design principles of collateral sensitivity-based dosing strategies. Nature Communications. 12: 5691. PMID 34584086 DOI: 10.1038/s41467-021-25927-3 |
0.166 |
|
| 2018 |
Yin A, Yamada A, Stam WB, van Hasselt JGC, van der Graaf PH. Quantitative systems pharmacology analysis of drug combination and scaling to humans: the interaction between noradrenaline and vasopressin on vasoconstriction. British Journal of Pharmacology. PMID 29859008 DOI: 10.1111/bph.14385 |
0.166 |
|
| 2015 |
Välitalo PA, Griffioen K, Rizk ML, Visser SA, Danhof M, Rao G, van der Graaf PH, van Hasselt JG. Structure-Based Prediction of Anti-infective Drug Concentrations in the Human Lung Epithelial Lining Fluid. Pharmaceutical Research. PMID 26626793 DOI: 10.1007/s11095-015-1832-x |
0.166 |
|
| 2009 |
Wirtz PW, Verschuuren JJ, Van Dijk JG, De Kam ML, Schoemaker RC, Van Hasselt JGC, Titulaer MJ, Tjaden UR, Den Hartigh J, Van Gerven JMA. Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of lambert-eaton myasthenic syndrome: A randomized, double-blind, placebo-controlled, crossover study Clinical Pharmacology and Therapeutics. 86: 44-48. PMID 19357643 DOI: 10.1038/clpt.2009.35 |
0.162 |
|
| 2022 |
Aulin LBS, Tandar ST, van Zijp T, van Ballegooie E, van der Graaf PH, Saleh MAA, Välitalo P, van Hasselt JGC. Physiologically Based Modelling Framework for Prediction of Pulmonary Pharmacokinetics of Antimicrobial Target Site Concentrations. Clinical Pharmacokinetics. 1-14. PMID 36401151 DOI: 10.1007/s40262-022-01186-3 |
0.154 |
|
| 2016 |
Yamamoto Y, Välitalo PA, van den Berg DJ, Hartman R, van den Brink W, Wong YC, Huntjens DR, Proost JH, Vermeulen A, Krauwinkel W, Bakshi S, Aranzana-Climent V, Marchand S, Dahyot-Fizelier C, Couet W, ... ... van Hasselt JG, et al. A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site Concentrations. Pharmaceutical Research. PMID 27864744 DOI: 10.1007/s11095-016-2065-3 |
0.154 |
|
| 2020 |
Guo T, van Hest RM, Zwep LB, Roggeveen LF, Fleuren LM, Bosman RJ, van der Voort PHJ, Girbes ARJ, Mathot RAA, Elbers PWG, van Hasselt JGC. Correction to: Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients. Pharmaceutical Research. 37: 223. PMID 37452467 DOI: 10.1007/s11095-020-02934-5 |
0.153 |
|
| 2011 |
Dumont GJH, Van Hasselt JGC, De Kam M, Van Gerven JMA, Touw DJ, Buitelaar JK, Verkes RJ. Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers Journal of Psychopharmacology. 25: 478-489. PMID 20817749 DOI: 10.1016/S0924-977X(10)70288-1 |
0.148 |
|
| 2016 |
De Cock PA, Mulla H, Desmet S, De Somer F, McWhinney BC, Ungerer JP, Moerman A, Commeyne S, Vande Walle J, Francois K, Van Hasselt JG, De Paepe P. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery. The Journal of Antimicrobial Chemotherapy. PMID 27999040 DOI: 10.1093/jac/dkw496 |
0.146 |
|
| 2011 |
Liem-Moolenaar M, de Boer P, Timmers M, Schoemaker RC, van Hasselt JGC, Schmidt S, van Gerven JMA. Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects British Journal of Clinical Pharmacology. 71: 886-898. PMID 21306419 DOI: 10.1111/j.1365-2125.2011.03936.x |
0.143 |
|
| 2023 |
Tandar ST, Aulin LBS, Leemkuil EMJ, Liakopoulos A, van Hasselt JGC. Semi-mechanistic modeling of resistance development to β-lactam and β-lactamase-inhibitor combinations. Journal of Pharmacokinetics and Pharmacodynamics. PMID 38008877 DOI: 10.1007/s10928-023-09895-3 |
0.141 |
|
| 2023 |
Liu F, Aulin LBS, Manson ML, Krekels EHJ, van Hasselt JGC. Unraveling the Effects of Acute Inflammation on Pharmacokinetics: A Model-Based Analysis Focusing on Renal Glomerular Filtration Rate and Cytochrome P450 3A4-Mediated Metabolism. European Journal of Drug Metabolism and Pharmacokinetics. 48: 623-631. PMID 37715056 DOI: 10.1007/s13318-023-00852-6 |
0.138 |
|
| 2015 |
Klumpers LE, Beumer TL, Van Hasselt JGC, Lipplaa A, Karger LB, Kleinloog HD, De Kam ML, Van Gerven JMA. Novel Δ9-tetrahydrocannabinol formulation Namisol has beneficial pharmacokinetics and promising pharmacodynamic effects | Namisol: Een nieuwe formulering van Δ9-tetrahydrocannabinol met gunstige farmacokinetiek en veelbelovende farmacodynamische effecten Pharmaceutisch Weekblad. 150: 122-131. |
0.137 |
|
| 2021 |
Keij FM, Koch BEV, Lozano Vigario F, Simons SHP, van Hasselt JGC, Taal HR, Knibbe CAJ, Spaink HP, Reiss IKM, Krekels EHJ. Zebrafish larvae as experimental model to expedite the search for new biomarkers and treatments for neonatal sepsis. Journal of Clinical and Translational Science. 5: e140. PMID 34422320 DOI: 10.1017/cts.2021.803 |
0.137 |
|
| 2003 |
van Hasselt JD. What doctors should look for in patients presenting with erectile dysfunction South African Psychiatry Review. 6: 29-30. |
0.134 |
|
| 2023 |
Gülave B, Budda D, Saleh MA, van Hasselt JC, de Lange EC. Does nonlinear blood-brain barrier transport matter for (lower) morphine dosing strategies? European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 187: 106482. PMID 37247795 DOI: 10.1016/j.ejps.2023.106482 |
0.13 |
|
| 2024 |
den Hartog I, Zwep LB, Meulman JJ, Hankemeier T, van de Garde EMW, van Hasselt JGC. Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia. Metabolomics : Official Journal of the Metabolomic Society. 20: 35. PMID 38441696 DOI: 10.1007/s11306-024-02091-5 |
0.129 |
|
| 2021 |
Mehta K, Spaink HP, Ottenhoff THM, van der Graaf PH, van Hasselt JGC. Host-directed therapies for tuberculosis: quantitative systems pharmacology approaches. Trends in Pharmacological Sciences. PMID 34916092 DOI: 10.1016/j.tips.2021.11.016 |
0.125 |
|
| 2021 |
den Hartog I, Zwep LB, Vestjens SMT, Harms AC, Voorn GP, de Lange DW, Bos WJW, Hankemeier T, van de Garde EMW, van Hasselt JGC. Metabolomic profiling of microbial disease etiology in community-acquired pneumonia. Plos One. 16: e0252378. PMID 34086721 DOI: 10.1371/journal.pone.0252378 |
0.124 |
|
| 2018 |
Aulin LBS, Valitalo PA, Rizk ML, Visser SAG, Rao G, van der Graaf PH, van Hasselt JGC. Validation of a Model Predicting Anti-infective Lung Penetration in the Epithelial Lining Fluid of Humans. Pharmaceutical Research. 35: 26. PMID 29368211 DOI: 10.1007/s11095-017-2336-7 |
0.123 |
|
| 2023 |
Bock M, Theut AM, van Hasselt JGC, Wang H, Fuursted K, Høiby N, Lerche CJ, Ihlemann N, Gill S, Christiansen U, Nielsen HL, Lemming L, Elming H, Povlsen JA, Bruun NE, et al. Attainment of target antibiotic levels by oral treatment of left-sided infective endocarditis: a POET substudy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36947131 DOI: 10.1093/cid/ciad168 |
0.123 |
|
| 2021 |
Poppe M, Clodi C, Schriefl C, Mueller M, Sunder-Plaßmann R, Reiter B, Rechenmacher M, van Os W, van Hasselt JGC, Holzer M, Herkner H, Schwameis M, Jilma B, Schoergenhofer C, Weiser C. Targeted temperature management after cardiac arrest is associated with reduced metabolism of pantoprazole - A probe drug of CYP2C19 metabolism. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 146: 112573. PMID 34959115 DOI: 10.1016/j.biopha.2021.112573 |
0.123 |
|
| 2024 |
Mehta K, Balazki P, van der Graaf PH, Guo T, van Hasselt JGC. Predictions of Bedaquiline Central Nervous System Exposure in Patients with Tuberculosis Meningitis Using Physiologically based Pharmacokinetic Modeling. Clinical Pharmacokinetics. PMID 38530588 DOI: 10.1007/s40262-024-01363-6 |
0.12 |
|
| 2024 |
van Os W, Pham AD, Eberl S, Minichmayr IK, van Hasselt JGC, Zeitlinger M. Integrative model-based comparison of target site-specific antimicrobial effects: a case study with ceftaroline and lefamulin. International Journal of Antimicrobial Agents. 107148. PMID 38508535 DOI: 10.1016/j.ijantimicag.2024.107148 |
0.12 |
|
| 1951 |
van HASSELT JA. Glioblastosis. | Glioblastose. Nederlands Tijdschrift Voor Geneeskunde. 95: 79-81. PMID 14806670 |
0.12 |
|
| 2022 |
Liu F, Aulin LBS, Guo T, Krekels EHJ, Moerland M, van der Graaf PH, van Hasselt JGC. Modelling inflammatory biomarker dynamics in a human lipopolysaccharide (LPS) challenge study using delay differential equations. British Journal of Clinical Pharmacology. 88: 5420-5427. PMID 35921300 DOI: 10.1111/bcp.15476 |
0.114 |
|
| 2022 |
Liu F, Aulin LBS, Kossen SSA, Cathalina J, Bremmer M, Foks AC, van der Graaf PH, Moerland M, van Hasselt JGC. A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsis. Journal of Pharmacokinetics and Pharmacodynamics. 49: 645-655. PMID 36261775 DOI: 10.1007/s10928-022-09828-6 |
0.112 |
|
| 2021 |
Thomson KM, Dyer C, Liu F, Sands K, Portal E, Carvalho MJ, Barrell M, Boostrom I, Dunachie S, Farzana R, Ferreira A, Frayne F, Hassan B, Jones E, Jones L, ... ... van Hasselt JGC, et al. Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS). The Lancet. Infectious Diseases. PMID 34384533 DOI: 10.1016/S1473-3099(21)00050-5 |
0.106 |
|
| 2022 |
Vinkenoog M, Steenhuis M, Brinke AT, van Hasselt JGC, Janssen MP, van Leeuwen M, Swaneveld FH, Vrielink H, van de Watering L, Quee F, van den Hurk K, Rispens T, Hogema B, van der Schoot CE. Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors. Frontiers in Immunology. 13: 821721. PMID 35296077 DOI: 10.3389/fimmu.2022.821721 |
0.106 |
|
| 2022 |
Kok M, Maton L, van der Peet M, Hankemeier T, van Hasselt JGC. Unraveling antimicrobial resistance using metabolomics. Drug Discovery Today. 27: 1774-1783. PMID 35341988 DOI: 10.1016/j.drudis.2022.03.015 |
0.099 |
|
| 2017 |
Goulooze SC, Krekels EHJ, van Dijk M, Tibboel D, van der Graaf PH, Hankemeier T, Knibbe CAJ, van Hasselt JGC. Towards personalized treatment of pain using a quantitative systems pharmacology approach. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. S32-S38. PMID 28506867 DOI: 10.1016/j.ejps.2017.05.027 |
0.096 |
|
| 2023 |
Bock M, Van Hasselt JGC, Schwartz F, Wang H, Høiby N, Fuursted K, Ihlemann N, Gill S, Christiansen U, Bruun NE, Elming H, Povlsen JA, Køber L, Høfsten DE, Fosbøl EL, et al. Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis. The Journal of Antimicrobial Chemotherapy. 78: 2840-2848. PMID 37823408 DOI: 10.1093/jac/dkad316 |
0.093 |
|
| 2009 |
Dumont GJ, Kramers C, Sweep FC, Touw DJ, Van Hasselt JG, De Kam M, Van Gerven JM, Buitelaar JK, Verkes RJ. Cannabis coadministration potentiates the effects of ecstasy on heart rate and temperature in humans Clinical Pharmacology and Therapeutics. 86: 160-166. PMID 19440186 DOI: 10.1038/Clpt.2009.62 |
0.09 |
|
| 2020 |
Aulin LBS, Koumans CIM, Haakman Y, van Os W, Kraakman MEM, Gooskens J, Smits WK, Liakopoulos A, van Hasselt JGC. Distinct evolution of colistin resistance associated with experimental resistance evolution models in Klebsiella pneumoniae. The Journal of Antimicrobial Chemotherapy. PMID 33150358 DOI: 10.1093/jac/dkaa450 |
0.087 |
|
| 2019 |
Calizo RC, Bhattacharya S, van Hasselt JGC, Wei C, Wong JS, Wiener RJ, Ge X, Wong NJ, Lee JJ, Cuttitta CM, Jayaraman G, Au VH, Janssen W, Liu T, Li H, et al. Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity. Nature Communications. 10: 2061. PMID 31053734 DOI: 10.1038/S41467-019-09936-X |
0.087 |
|
| 2022 |
Aulin LBS, Kleijburg A, Moerland M, van Hasselt JGC. Characterizing the kinetics of presepsin and associated inflammatory biomarkers in human endotoxemia. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 71: 999-1001. PMID 35861876 DOI: 10.1007/s00011-022-01610-1 |
0.084 |
|
| 2017 |
Xiong Y, Soumillon M, Wu J, Hansen J, Hu B, van Hasselt JGC, Jayaraman G, Lim R, Bouhaddou M, Ornelas L, Bochicchio J, Lenaeus L, Stocksdale J, Shim J, Gomez E, et al. A Comparison of mRNA Sequencing with Random Primed and 3'-Directed Libraries. Scientific Reports. 7: 14626. PMID 29116112 DOI: 10.1038/S41598-017-14892-X |
0.082 |
|
| 2021 |
Zwep LB, Haakman Y, Duisters KLW, Meulman JJ, Liakopoulos A, van Hasselt JGC. Identification of antibiotic collateral sensitivity and resistance interactions in population surveillance data. Jac-Antimicrobial Resistance. 3: dlab175. PMID 34859221 DOI: 10.1093/jacamr/dlab175 |
0.081 |
|
| 2022 |
Liakopoulos A, Aulin LBS, Buffoni M, Fragkiskou E, van Hasselt JGC, Rozen DE. Allele-specific collateral and fitness effects determine the dynamics of fluoroquinolone resistance evolution. Proceedings of the National Academy of Sciences of the United States of America. 119: e2121768119. PMID 35476512 DOI: 10.1073/pnas.2121768119 |
0.076 |
|
| 2021 |
Rahman R, Zatorski N, Hansen J, Xiong Y, van Hasselt JGC, Sobie EA, Birtwistle MR, Azeloglu EU, Iyengar R, Schlessinger A. Protein structure-based gene expression signatures. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33941686 DOI: 10.1073/pnas.2014866118 |
0.069 |
|
| 2013 |
Klumpers LE, Roy C, Ferron G, Turpault S, Poitiers F, Pinquier JL, van Hasselt JGC, Zuurman L, Erwich FAS, van Gerven JMA. Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans British Journal of Clinical Pharmacology. 76: 65-77. PMID 23278647 DOI: 10.1111/bcp.12071 |
0.064 |
|
| 2023 |
den Hartog I, Karu N, Zwep LB, Voorn GP, van de Garde EMW, Hankemeier T, van Hasselt JGC. Differential metabolic host response to pathogens associated with community-acquired pneumonia. Metabolism Open. 18: 100239. PMID 37025095 DOI: 10.1016/j.metop.2023.100239 |
0.06 |
|
| 2014 |
Bloch EM, Shah A, Kaidarova Z, Laperche S, Lefrere JJ, van Hasselt J, Zacharias P, Murphy EL, Kayembe MK, Chinorumba A, Gonnetsweng GG, Mphele J, Verde C, Rocha J, Okyere M, et al. A pilot external quality assurance study of transfusion screening for HIV, HCV and HBsAG in 12 African countries Vox Sanguinis. 107: 333-342. PMID 25052195 DOI: 10.1111/vox.12182 |
0.054 |
|
| 1949 |
VAN HASSELT JA. Not available | Sarcoid van Besnier-Boeck in een spier. Nederlands Tijdschrift Voor Geneeskunde. 93: 1280. PMID 18150390 |
0.052 |
|
| 2012 |
Van Den Berg K, Van Hasselt J, Bloch E, Crookes R, Kelley J, Berger J, Ingram C, Dippenaar A, Thejpal R, Littleton N, Elliz T, Reubenson G, Cotton M, Hull JC, Moodley P, et al. A review of the use of blood and blood products in HIV-infected patients Southern African Journal of Hiv Medicine. 13: 87-103. |
0.05 |
|
| 1948 |
VAN HASSELT JA. Not available | Rheumatische aandoeningen van het zenuwstelsel. Nederlands Tijdschrift Voor Geneeskunde. 92: 67-69. PMID 18902973 |
0.05 |
|
| 1949 |
VAN HASSELT JA. [Not Available] | Spongioblastosis multiformis gangliodes Nederlands Tijdschrift Voor Geneeskunde. 93: 1278-1280. PMID 18145118 |
0.048 |
|
| 1948 |
VAN HASSELT JA. Not Available | Rheumatische hersenaandoeningen Nederlands Tijdschrift Voor Geneeskunde. 92: 3356. PMID 18099274 |
0.048 |
|
| 2018 |
Krzyzanski W, van Hasselt JGC. Special issue: mathematical pharmacology. Journal of Pharmacokinetics and Pharmacodynamics. 45: 1. PMID 29299711 DOI: 10.1007/s10928-017-9566-5 |
0.042 |
|
| 2018 |
Krzyzanski W, van Hasselt JGC. Special issue: mathematical pharmacology. Journal of Pharmacokinetics and Pharmacodynamics. 45: 1. PMID 29299711 DOI: 10.1007/s10928-017-9566-5 |
0.042 |
|
| 1983 |
van Hasselt JL. Report GZ'83 is misleading! Farewell address by J. L. van Hasselt, president of the Section Mental Health Care of the NZR (National Hospital Council) | Rapport GZ'83 is misleidend! Afscheidsrede van J. L. van Hasselt, voorzitter van de Sectie geestelijke gezondheidszorg van de NZR. Tijdschrift Voor Ziekenverpleging. 36: 789-790. PMID 6560927 |
0.037 |
|
| 1885 |
van Hasselt J, de Koning J. Een rijst-polder - Proeve eener berekening van het rentegevend vermogen van gronden op Java, door middel van landbouw-werktuigen en stoom in cultuur gebracht en met padie beplant De Economist. 34: 577-616. DOI: 10.1007/BF02184847 |
0.026 |
|
| 2018 |
Saleh MAA, van de Garde EMW, van Hasselt JGC. Host-response biomarkers for the diagnosis of bacterial respiratory tract infections. Clinical Chemistry and Laboratory Medicine. PMID 30183665 DOI: 10.1515/cclm-2018-0682 |
0.025 |
|
| 1992 |
Van Hasselt JP. Reservoir compaction and surface subsidence resulting from oil and gas production. A review of theoretical and experimental research approaches Geologie En Mijnbouw. 71: 107-118. |
0.025 |
|
| 2003 |
Van Riel CBM, Van Hasselt JJ. Conversion of organizational identity research findings into actions Corporate and Organizational Identities: Integrating Strategy, Marketing, Communication and Organizational Perspectives. 156-174. DOI: 10.4324/9780203361726 |
0.017 |
|
| 1987 |
van Hasselt JC, Kaper HP. NEW LINES: THE NEW FLEVO LINE, AN ENVIRONMENT-FRIENDLY PROJECT. Rail International. 13: 38-44. |
0.014 |
|
| 1952 |
VAN HASSELT JA. Medulloblastoma. | Medullo-blastomen. Nederlands Tijdschrift Voor Geneeskunde. 96: 1181-1182. PMID 14957135 |
0.014 |
|
| 1976 |
Huijben MJ, van Hasselt JP, van der Weg K, van der Lugt W. Density of liquid sodium-potassium and potassium-rubidium alloys Scripta Metallurgica. 10: 571-574. DOI: 10.1016/0036-9748(76)90265-9 |
0.01 |
|
| 1951 |
van HASSELT JA. Traumatic pontile hemorrhage. | Traumatische ponsbloedingen. Nederlands Tijdschrift Voor Geneeskunde. 95: 77-79. PMID 14806669 |
0.01 |
|
| 1934 |
van der Horst L, van Hasselt JA. Syringomyelie oder Tumor medullae? Deutsche Zeitschrift FüR Nervenheilkunde. 133: 129-135. DOI: 10.1007/BF01760232 |
0.01 |
|
| 1910 |
van Hasselt JFB. Notiz zur Pepsin-Chymosinfrage Hoppe-Seyler's Zeitschrift Fur Physiologische Chemie. 70: 171-185. DOI: 10.1515/bchm2.1910.70.2-3.171 |
0.01 |
|
| Hide low-probability matches. |
